ANTI-INFLAMMATORY COMPOSITIONS CONTAINING EICOSAPENTAENOIC ACID BEARING MONOGALACTOSYLDIACYLGLYCEROL AND METHODS RELATING THERETO

摘要

Disclosed are topical anti-inflammatory compositions containing 0.1% to 10% by weight of a monogalactosyl dieicosapentaenoyl glycerol having esterified eicosapentaenoic acid residues (MGDG-EPA); anti-inflammatory compositions are formulated using a purified microalgal lipid preparation containing 30% to 100% by weight of MGDG-EPA; methods of making the microalgal lipid preparation; methods of treating inflammation by administering the topical anti-inflammatory compositions to a subject in need thereof.